A large proportion of US adults who are prescribed Schedule II stimulants are simultaneously receiving other CNS agents including benzodiazepines, opioids, and antidepressants - a potentially dangerous practice.Investigators analyzed prescription drug claims for over 9.1 million US adults over a 1-year period and found that 276,223 (3%) had used a Schedule II stimulant, such as methylphenidate and amphetamines, during that time.
[
add
]
[
|
|
...
]